Evaluation of retinal thickness in patients with Glaucoma using Prostaglandin eye drops undergoing Trabeculectomy surgery

Not Applicable

Active, not recruiting

• Conditions: Glaucoma; H40.9

• Registration Number: RBR-5y44mmj
• Lead Sponsor: niversidade Federal de Goiás

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-07-31
• Study Start: 2023-09-30
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Pacients of all ages with Primary Glaucoma; Primary Open Angle Glaucoma; Primary Narrow Angle Glaucoma; Normal Pressure Glaucoma; Pigmentary Glaucoma; Pseudoexfoliative Glaucoma; visual field changes; typical defect compatible with glaucomatous lesion and/or typical anatomical involvement of the optic disc or nerve fiber layer of the retina (such as Hoyt´s sign, cupping ratio greater than 0.7, localized neural rhyme defect, or cupping asymmetry); indication of trabeculectomy at medical discretion (example: uncontrolled intraocular pressure or impossibility of using medication due to allergy or financial conditions); need to reduce the intraocular pressure by at least 20% in relation
to the baseline in the postoperative period for inclusion; intraocular pressure above the traget established for the case and with medication

Exclusion Criteria

Any pathology that could interfere with the results of the tests; low quality of exams; any previous macular pathology; use of diamox; advanced glaucoma with maximal therapy; advanced glaucoma with impaired fixation; any surgical complications including hypotonia in any evaluation; performing combined cataract and glaucoma surgery; need for surgical intervention; reintrodution of therapy with prostaglandin analogues

Study & Design

• Study Type: Intervention
• Study Design: Not specified